The present study analyzed coronary sinus blood flow alterations after dipyridamole induced coronary vasodilation in seven patients whose endomyocardial biopsies evidenced no sign of rejection (group 1) and in five patients with histologic signs of rejection (group 2) after orthotopic heart transplantation. All patients were treated with cyclosporine and prednisone and some with azathioprine and had normal coronary arteriograms. Coronary sinus blood flow and coronary resistance were measured before and after intravenous dipyridamole (0.18 mg/ kg/min over 4 minutes). Basal values were similar in groups 1 and 2 for coronary sinus blood flow (166+34 compared with 181±39 mUmin, respectively), coronary resistance (0.62±10 compared with 0.52±13 mm Hg/ml/min, respectively), coronary sinus blood oxygen content (5.7±1.6 compared with 4.5±0.9 ml/100 ml, respectively) and arterial-coronary sinus blood oxygen difference (10.6±1.3 compared with 10.3±1.8 ml/100 ml, respectively). After dipyridamole, patients with heart rejection had lower coronary sinus blood flow and coronary sinus blood oxygen content than did patients without heart rejection (263±76 in group 2 compared with 505±96 mVlmin in group 1,p <0.001, and 7.6±0.9 in group 2 compared with 13.3± 1.8 ml/ 100 ml in group 1, p<0.001 respectively) and had higher coronary resistance and arterialcoronary sinus blood oxygen difference than did patients without heart rejection (0.34±0.15 in group 2 compared with 0.16±0.02 mm Hg/ml/min in group 1, p <0.02, and 7.0±1.4 in group 2 compared with 3.3 ±0.8 ml/100 ml in group 1, p <0.001, respectively). Coronary flow reserve evaluated by the dipyridamole:basal coronary sinus blood flow ratio and resistance reserve evaluated by the basal:dipyridamole coronary resistance ratio were significantly reduced in patients with heart rejection (1.56±0.09 in group 2 compared with 3.09±0.44 in group 1, p<0.001, and 1.63±0.30 in group 2 compared with 3.89±0.82 in group 1, p<0.001, respectively). These data indicate that capacity of the intramyocardial coronary circulation to vasodilate is severely impaired during heart rejection. (Circulation 1989;79:59-65) D uring cardiac allograft rejection, endomyocardial biopsies evidenced alterations suggesting that the coronary microcirculation is involved and that myocardial ischemia might be a component of the rejection process (endothelial edema, intimal proliferation, thrombosis, vascular necrosis1-5 and foci of myocardial infarction3 have been reported). These alterations are similar to histopathologic changes documented during rejec-From the Service d'Explorations Fonctionnelles, INSERM tion in the vessels of the renal,67 hepatic,8 and pulmonary9 circulations. Aside from morphologic data, studies of coronary blood flow indicate that in the absence of rejection, the response of the coronary circulation to vasodilator drugs is normal in orthotopic heart transplants.10"'1 On the other hand, it has been shown that during dog heart allograft rejection, the decrease in coronary blood flow was proportional to the decrease in cardiac output'2-'4 and the peak reactive hyperemia13 and the coronary responses to adenosine and dipyridamole were impaired.15 Altered vasomotor changes have also been evidenced during kidney grafts rejection.16"17
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Patients and Methods Patient Selection
The study group comprised 12 patients undergoing orthotopic heart transplantation at Hopital Henri Mondor (Service de Chirurgie Thoracique et Cardiovasculaire, Creteil, France). All patients received immunosuppressive therapy with prednisone (0.3 mg/kg/day) and cyclosporine. The dose of cyclosporine (2-5 mg/kg/day) was adjusted to maintain cyclosporine levels between 600 and 900 ng/ml blood. Five out of the 12 patients received azathioprine (1.5 mg/kg/day). Histologic findings on right ventricular endomyocardial biopsy were used to separate the patients into two groups. At least three samples were obtained, and biopsies were graded according to Billingham criteria. 19 Group 1 comprised seven patients whose endomyocardial biopsies did not evidence any sign of rejection, as reflected by the absence of cellular infiltration or myocyte necrosis. Group 2 included five patients whose endomyocardial biopsies evidenced mildto-moderate rejection defined by cellular infiltration without or with myocyte necrosis. None of them had a significant decrease in electrocardiographic voltage. The coronary blood flow evaluation procedure was achieved the day after endomyocardial biopsy. Sex, age, delay after surgery, treatment of each patient, and number of previous rejection episodes are presented in Table 1 . Catheterization Procedure Cardiac catheterization was performed after the patients gave informed consent. All patients were in the fasting state for at least 12 hours before the procedure. No premedication was administered.
With 1% lidocaine for local anesthesia, a 7F high-fidelity, double-tipped micromanometer catheter (PC-770, Millar Instruments, Houston, Texas) was placed into the left ventricle through a femoral artery and positioned to record simultaneously left ventricular and aortic pressures. A 7F sheath was placed into the other femoral artery for left ventriculography and coronary arteriography. A 7F Swan-Ganz thermodilution catheter (Edwards Laboratories, Irvine, California) was placed into the pulmonary artery through a femoral vein for cardiac output determinations (Cardiac Output Computer Model 9520 A, Edwards Laboratories). A 7F coronary sinus thermodilution catheter (Wilton Webster Laboratories, Altadena, California) was inserted into the left subclavian vein or the other femoral vein and positioned in the coronary sinus for coronary sinus blood flow measurements. The position of the catheter was controlled by fluoroscopy before coronary sinus blood flow was measured to place the proximal thermistor in front of the posterior interventricular vein entering the coronary sinus.
Protocol
Left ventricular angiography (1 ml ioxaglate meglumine/kg body wt) and coronary arteriography were performed. An interval of 30 minutes was allowed to eliminate the effects of contrast material.20 Basal left ventricular, aortic and right atrial pressures, cardiac output, and coronary sinus blood flow were recorded. Arterial, pulmonary artery, and coronary . :
sinus blood samples were obtained. The entire procedure was repeated 5 minutes after a right atrial infusion of 0.18 mg/kg/min dipyridamole over 4 minutes. 21, 22 To analyze the effects of a superimposed hyperemic stimulus, 8 ml contrast medium was infused into the left coronary artery23,24 during the basal state and after administration of dipyridamole while coronary sinus blood flow was continuously recorded.
Data Analysis and Calculation
Cardiac output and cardiac index (cardiac output:body surface area) were determined by the thermodilution method, and coronary sinus blood flow was determined by the continuous thermodilution method25 (1 ml/sec saline infusion). Heart rate, left ventricular end-diastolic and systolic pressures, mean aortic and mean right atrial pressures, and systemic vascular resistances were calculated by a catheterization data analysis computer system (Model 5600 M, Hewlett-Packard, Andover, Massachusetts) that performed on-line analysis of nine beats for averaging respiratory variations. Left ventricular end-diastolic and end-systolic volumes, as well as ejection fraction, were calculated from the monoplane angiogram (100 frames/sec) in a 30°right anterior oblique projection by the area-length method. 26 Left ventricular mass was calculated according to the equation of Trenouth et al. 27 Coronary sinus blood flow (ml/min) was used to calculate coronary resistance as mean aortic pressure minus left ventricular end-diastolic pressure (mm Hg) divided by coronary sinus blood flow (ml/ min). Oxygen content of blood samples was determined by the galvanic cell method (Lex°2 Con K, Lexington Instruments, Waltham, Massachusetts).
Statistical Methods
Mean values (±SD) were calculated for each variable. Data from group 1 and group 2 patients were compared by an unpaired t test. Control and dipyridamole data in each group were compared by a paired t test. Significance was at thep < 0.05 level. Results
Angiographic Data
Angiographic data evidenced similar values of left ventricular volumes, mass, and ejection fraction in the two groups of patients (Table 2) . Coronary arteriography was normal in all patients.
Results of Endomyocardial Biopsies
In group 1 patients, endomyocardial biopsies did not evidence any sign of rejection. However, endocardial thickening was seen in three patients and mild interstitial fibrosis was seen in two other patients. Data from results of group 2 patients are depicted in Table 3 . In this group, arteriolar vasculitis (i.e., intramural inflammatory cells) was evidenced in patient 9 and endocardial thickening was observed in patient 8.
Hemodynamic Data
Basal values of left ventricular pressures, cardiac index, systemic vascular resistances, and rate-pressure product were comparable in both groups. Mean right atrial pressure and heart rate were significantly higher in patients with heart rejection ( Table 4 ). After dipyridamole infusion, cardiac index was increased and left ventricular systolic pressure was reduced in patients without heart rejection. A trend to similar hemodynamic alterations was observed in patients with heart rejection. Mean aortic pressure and systemic vascular resistances were decreased significantly in both groups. Left ventricular enddiastolic pressure and the rate-pressure product did not vary significantly in both groups. Mean right atrial pressure did not vary significantly and remained higher in group 2 patients. Heart rate increased significantly only in group 1 patients and was not different in the two groups (Table 4 ). 
Coronary Hemodynamics and Myocardial Metabolism
Basal values of coronary sinus blood flow, coronary resistance, coronary sinus blood oxygen content, and arterial-coronary sinus blood oxygen difference were not significantly different in the two groups.
After dipyridamole infusion (Figure 1 ), coronary sinus blood flow and coronary sinus blood oxygen content increased, and coronary resistance and arterial-coronary sinus blood oxygen difference decreased in both groups. However, the coronary sinus blood flow increase and the coronary resistance decrease were significantly higher in group 1 than in group 2 patients (respectively, + 209 ± 44% compared with + 45 ± 21% for the coronary sinus blood flow increase, p< 0.001, and -73 ± 5% compared with -37±14% for the coronary resistance decrease, p <0.001). Concomitantly, the coronary sinus blood oxygen content rise and the arterialcoronary sinus blood oxygen difference reduction were significantly higher in group 1 than in group 2 patients (respectively, + 145 ± 68% compared with + 78 ± 49% for the coronary sinus blood oxygen content increase, p<0.001, and -67±11% compared with -31±15% for the arterial-coronary sinus blood oxygen difference decrease,p <0.001). Of importance, after dipyridamole there was no overlap between the two groups in any of these coronary hemodynamic and metabolic variables. Thus, coronary flow reserve evaluated by the dipyridamole: basal coronary sinus blood flow ratio and coronary resistance reserve evaluated by the basal: dipyridamole resistance ratio were significantly lower in group 2 than in group 1 patients ( Figure 2 ) (respectively, 1.56 ± 0.09 compared with 3.09±0.44, p<0.001, for the flow reserve, and 1.63 ± 0.30 compared with 3.89 ±0.82,p <0.001, for the resistance reserve).
Discussion
Cardiac rejection is characterized by rapid and widespread capillary and arterial medial alterations that precede lymphocyte and monocyte myocardial infiltration.5 These vascular alterations are similar to those observed in other homografts rejection6-9 and could be responsible for focal myocardial necrosis that is probably due to ischemia.328 Previous animal studies have evidenced that postocclusive coronary hyperemia and response to vasodilator drugs were impaired during allograft rejection and that those alterations develop earlier than decreases in basal coronary flow level.12-15 Obviously, most animal transplants were performed with little or no immunosuppression, and rejection was more fulminant than that occurring in immunosuppressed patients. As well, the temporal relation of vascular injury to myocyte injury cannot be assumed to be the same in animal models as in treated patients.
The major finding of the present study is that a significant reduction in the coronary vascular response to dipyridamole-induced vasodilation was observed in patients with allograft rejection when compared with patients without rejection (i.e., coronary flow and resistance reserve were dramatically reduced during heart rejection). Although coronary arterial lesions due to accelerated coronary atherosclerosis in patients treated with cyclosporine and prednisone could impair coronary reserve,29,30 the lower coronary reserve in patients with heart rejection found in this study should be linked to abnormalities of the distal circulation because there was no obstructive lesion on large coronary arteries in any of our patients. Nevertheless, atheromatous plaques or intimal lesions or both without luminal narrowing could have impaired normal vasodilation of the epicardial arteries after dipyridamole and might have weakly contributed to the reduction of the coronary reserve, but such a mechanism cannot explain the differences between the two groups.
An increased fibrotic tissue due to previous episodes of rejection could result in extravascular compression of coronary microcirculation within the myocardium, which could reduce the number of functional vessels or impair the capacity of arteriolar vasodilation.'3 However, it must be pointed out that this reduction of coronary reserve in group 2 patients should have occurred in areas of functional myocardium with normal oxygen consumption but not in fibrotic areas because after dipyridamole, the coronary sinus blood oxygen content was lower and the arterial-coronary sinus blood oxygen difference was higher than in group 1 patients. Alternatively, the reduced coronary reserve during rejection could be the result of the limitation of vasodilation due to 1) marked interstitial edema,28 2) structural alterations that occurred in the vessels themselves,15 3) obstruction within the microvascular bed by thrombosis or obliterative intimal proliferation or both,3 or 4) metabolically or immunologicly related responsiveness of vascular wall. It has been demonstrated that those alterations could be nearly reversible when immunosuppressive therapy is provided and probably result to an almost normal coronary vasodilator capacity,4,5 which is observed in group 1 patients who had previous episodes of rejection. However, repetition of rejection episodes with acute microvascular abnormalities could result in progressive fibrosis or atherosclerosis or both of the microvessels and a gradual fall of the coronary vascular reserve.
Although it has been evidenced that cyclosporine could alter blood flow of renal transplants via stimulation of renin-angiotensin system, inhibition of prostaglandin-mediated vasodilation, cyclosporine a-agonism, or arteriolopathy,31'32 such a mechanism could not explain the differences between two groups of patients who received similar treatment.
Concerns related to coronary reserve evaluation and measurement of coronary blood flow in humans have been recently addressed. [33] [34] [35] The potential limitation of this study results from the thermodilution method used to measure the coronary blood flow because this method does not define the mass of myocardium being drained. However, it must be pointed out that the basal coronary sinus blood flow was comparable in the two groups when coronary sinus blood flow was twice in group 1 than in group 2 patients after dipyridamole. Furthermore, each patient served as his own control, and coronary reserve was evaluated by flow and resistance ratios. Because coronary reserve depends on the level of basal myocardial requirement, differences between the two groups could be the result of a higher basal coronary blood flow in group 2 patients due to higher basal oxygen demand. The results presented in this study evidenced that basal coronary sinus blood flow was comparable in the two groups and that, except for basal heart rate, all the determinants of basal myocardial oxygen consumption (i.e., left ventricular myocardial mass and volumes, left ventricular pressures, mean aortic pressure, cardiac index, systemic vascular resistances, and ratepressure product) were similar in the two groups. That hemodynamic and left ventricular function indexes were not different in patients with and without heart rejection is a common finding until late in the course of rejection. 13,19,36'37 In addition, the significantly lower coronary flow in group 2 than in group 1 patients after dipyridamole cannot result from any hemodynamic differences between the two groups because all the measured parameters related to the left ventricular oxygen requirement remained comparable. In the two patients (patients 10 and 11) who had the lowest ejection fractions, the lowest blood pressures, and the smallest increase in cardiac output after dipyridamole, results of endomyocardial biopsies were similar to those of the other patients of group 2 (Table 3 ) or group 1 in that coronary flow and resistance values were not different from that of the other patients of group 2 at either basal state or after dipyridamole infusion.
The low degree of coronary blood flow increase after dipyridamole in group 2 patients raises the point that dipyridamole-induced vasodilation could have been nonmaximal. However, a maximal coronary vasodilation was probably reached in group 1 as well as in group 2 patients because a superimposed vasodilator stimulus, that is, the injection of 8 ml contrast medium into the left coronary artery,24'38 was unable to further increase the coronary sinus blood flow.
In summary, the present study provides evidence that the capacity of coronary flow to increase and of coronary resistance to decrease during cardiac allograft rejection is greatly impaired, thereby confirming early experimental hemodynamic findings. [12] [13] [14] [15] That the impairment of coronary reserve during heart rejection is partly or totally reversible with rejection therapy could be reasonably expected because patients without heart rejection who had an average number of previous episodes of rejection similar to group 2 patients evidenced a higher coronary vascular reserve. However, this point remains to be demonstrated by iterative evaluations of coronary reserve before and after treatment of rejection.
The dramatically reduced vasodilator capacity in group 2 patients puts emphasis on the potential vulnerability of the myocardium to any increase in the metabolic requirements at the time of a heart rejection episode. In addition, our data may also be of clinical relevance for future research on the detection of heart rejection by noninvasive techniques.39A40 10. Paoloni HJ, Wilcken DEL: Inter-relations between the actions of dipyridamole, adenosine, aminophylline and propranolol on the coronary circulation of the transplanted dog heart.
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